• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number ERES25024X
Device Problem Fracture (1260)
Patient Problems Occlusion (1984); Injury (2348)
Event Date 02/27/2014
Event Type  malfunction  
Manufacturer Narrative
Zotarolimus-eluting stent fracture at initial implantation diagnosed with stentboost doi: 10.1177/2050313x16645754 please note that this device (endeavor resolute) is not marketed in the united states; however, it is similar to the united states marketed product (resolute integrity).This event is being reported only as a malfunction because of the similar device requirement in 803 which is limited to malfunctions.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Patient was admitted to er with unstable angina.Angiography showed 90% stenosis at the cx and obtuse marginal branch of the cx.The obtuse and cx were pre-dilated with a non-medtronic balloons.An endeavor resolute rx drug eluting stent was implanted at 12 atm in the side branch and post-dilated.Subsequently deploying the main branch non-medtronic balloon, a mini crush was performed and another endeavor resolute rx drug eluting stent was implanted at 20 atm into the cx body.The om was rewired and final kissing was performed with non-medtronic nc balloons.Thereafter, localized haziness suggesting thrombosis at first sight appeared in the main-branch stent, both in the proximal part and distal to the om take off.The patient had no symptom and was hemodynamically stable.Stentboost showed stent fracture and disruption.Another endeavor resolute stent was implanted at 14atm to cover the fracture sites.The final result was satisfactory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RESOLUTE RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8598763
MDR Text Key145238361
Report Number9612164-2019-01656
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/28/2015
Device Catalogue NumberERES25024X
Device Lot Number0006853833
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/10/2019
Date Device Manufactured08/28/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
Patient Weight65
-
-